News Release

Testing child's urine may help doctors identify risk for high blood pressure

Peer-Reviewed Publication

American Heart Association

Measuring sodium in a child's urine may help doctors identify those at risk for having high blood pressure later in life, according to a study presented at the American Heart Association High Blood Pressure Research Scientific Sessions 2013.

In a small study, researchers used a new protocol to quickly screen 19 children who were 10-19-year-olds. Researchers found that of the eight who retained sodium seven had high blood pressure.

The inability to properly excrete sodium in the body can occur during stress, such as when kids get nervous while in a doctor's office, so the children were asked to provide a urine sample before and after their visit to a physician. Sodium retention increases fluid in the blood vessels, which can impact blood pressure. High blood pressure can develop over time if the body can't properly regulate sodium, and is a serious risk factor for heart disease and stroke.

"Hypertension is no longer an adult disease," said Gregory Harshfield, Ph.D., study senior researcher and director of the Institute of the Georgia Prevention Center at the Medical College of Georgia at Georgia Regents University, Augusta, Ga. "The results of this test could also provide useful information that could help pediatricians better manage and treat hypertension in their patients," Harshfield said.

###

Co-authors and author disclosures are on the manuscript.

The National Heart, Lung, and Blood Institute funded the study.

For high blood pressure tools and information visit heart.org/hbp.

For the latest heart and stroke news, follow us on Twitter: @HeartNews.

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.